272 related articles for article (PubMed ID: 28063039)
21. Development of a bioengineered skin-humanized mouse model for psoriasis: dissecting epidermal-lymphocyte interacting pathways.
Guerrero-Aspizua S; García M; Murillas R; Retamosa L; Illera N; Duarte B; Holguín A; Puig S; Hernández MI; Meana A; Jorcano JL; Larcher F; Carretero M; Del Río M
Am J Pathol; 2010 Dec; 177(6):3112-24. PubMed ID: 20971736
[TBL] [Abstract][Full Text] [Related]
22. Dynamics and Transcriptomics of Skin Dendritic Cells and Macrophages in an Imiquimod-Induced, Biphasic Mouse Model of Psoriasis.
Terhorst D; Chelbi R; Wohn C; Malosse C; Tamoutounour S; Jorquera A; Bajenoff M; Dalod M; Malissen B; Henri S
J Immunol; 2015 Nov; 195(10):4953-61. PubMed ID: 26466959
[TBL] [Abstract][Full Text] [Related]
23. Review paper: preclinical models of psoriasis.
Danilenko DM
Vet Pathol; 2008 Jul; 45(4):563-75. PubMed ID: 18587106
[TBL] [Abstract][Full Text] [Related]
24. Protocol for Flow Cytometric Detection of Immune Cell Infiltration in the Epidermis and Dermis of a Psoriasis Mouse Model.
Lou F; Sun Y; Wang H
STAR Protoc; 2020 Dec; 1(3):100115. PubMed ID: 33377011
[TBL] [Abstract][Full Text] [Related]
25. Aldara-induced psoriasis-like skin inflammation: isolation and characterization of cutaneous dendritic cells and innate lymphocytes.
Wohn CT; Pantelyushin S; Ober-Blöbaum JL; Clausen BE
Methods Mol Biol; 2014; 1193():171-85. PubMed ID: 25151006
[TBL] [Abstract][Full Text] [Related]
26. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
27. Infiltration of T Cells into a Three-Dimensional Psoriatic Skin Model Mimics Pathological Key Features.
Lorthois I; Simard M; Morin S; Pouliot R
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987186
[TBL] [Abstract][Full Text] [Related]
28. Type1 Interferons Potential Initiating Factors Linking Skin Wounds With Psoriasis Pathogenesis.
Zhang LJ
Front Immunol; 2019; 10():1440. PubMed ID: 31293591
[TBL] [Abstract][Full Text] [Related]
29. Localization of the defect in skin diseases analyzed in the human skin graft-nude mouse model.
Briggaman RA
Curr Probl Dermatol; 1980; 10():115-26. PubMed ID: 7016453
[TBL] [Abstract][Full Text] [Related]
30. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
Nickoloff BJ
Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
[TBL] [Abstract][Full Text] [Related]
31. Statistical evaluation and experimental design of a psoriasis xenograft transplantation model treated with cyclosporin A.
Stenderup K; Rosada C; Alifrangis L; Andersen S; Dam TN
Exp Dermatol; 2011 May; 20(5):441-4. PubMed ID: 21426413
[TBL] [Abstract][Full Text] [Related]
32. Histological and immunocytochemical studies of human psoriatic lesions transplanted onto SCID mice.
Sugai J; Iizuka M; Kawakubo Y; Ozawa A; Ohkido M; Ueyama Y; Tamaoki N; Inokuchi S; Shimamura K
J Dermatol Sci; 1998 Jun; 17(2):85-92. PubMed ID: 9673889
[TBL] [Abstract][Full Text] [Related]
33. Anti-CD11a ameliorates disease in the human psoriatic skin-SCID mouse transplant model: comparison of antibody to CD11a with Cyclosporin A and clobetasol propionate.
Zeigler M; Chi Y; Tumas DB; Bodary S; Tang H; Varani J
Lab Invest; 2001 Sep; 81(9):1253-61. PubMed ID: 11555673
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
[TBL] [Abstract][Full Text] [Related]
35. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model.
Villadsen LS; Schuurman J; Beurskens F; Dam TN; Dagnaes-Hansen F; Skov L; Rygaard J; Voorhorst-Ogink MM; Gerritsen AF; van Dijk MA; Parren PW; Baadsgaard O; van de Winkel JG
J Clin Invest; 2003 Nov; 112(10):1571-80. PubMed ID: 14617758
[TBL] [Abstract][Full Text] [Related]
36. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model.
Boehncke WH; Zollner TM; Dressel D; Kaufmann R
J Cutan Pathol; 1997 Jan; 24(1):1-7. PubMed ID: 9027626
[TBL] [Abstract][Full Text] [Related]
37. The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaques.
Gordon KB; Bonish BK; Patel T; Leonardi CL; Nickoloff BJ
Br J Dermatol; 2005 Nov; 153(5):945-53. PubMed ID: 16225604
[TBL] [Abstract][Full Text] [Related]
38. Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model.
Nadeem A; Al-Harbi NO; Ansari MA; Al-Harbi MM; El-Sherbeeny AM; Zoheir KMA; Attia SM; Hafez MM; Al-Shabanah OA; Ahmad SF
Biochem Pharmacol; 2017 Jan; 124():69-82. PubMed ID: 27984001
[TBL] [Abstract][Full Text] [Related]
39. Gradual development of psoriatic skin lesions by constitutive low-level expression of IL-17A.
Wohn C; Brand A; van Ettinger K; Brouwers-Haspels I; Waisman A; Laman JD; Clausen BE
Cell Immunol; 2016 Oct; 308():57-65. PubMed ID: 26653007
[TBL] [Abstract][Full Text] [Related]
40. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
Sah SK; Park KH; Yun CO; Kang KS; Kim TY
Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
